Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 225,425,490 papers from all fields of science
Search
Sign In
Create Free Account
mosapramine
Known as:
3-chloro-5-(3-(2-oxo-1,2,3,5,6,7,8,8a-octahydroimidazo(1,2-a)pyridine-3-spiro-4'-piperidino)propyl)-10,11-dihydro-5H-dibenz(b,f)azepine
, Spiro(imidazo(1,2-a)pyridine-3(2H),4'-piperidin)-2-one, 1'-(3-(3-chloro-10,11-dihydro-5H-dibenz(b,f)azepin-5-yl)propyl)hexahydro-, dihydrochloride
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
2 relations
Broader (1)
Benzazepines
Narrower (1)
Y 516
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2000
2000
The effect of the antipsychotic drug mosapramine on the expression of Fos protein in the rat brain: comparison with haloperidol, clozapine and risperidone.
M. Fujimura
,
K. Hashimoto
,
K. Yamagami
Life Science
2000
Corpus ID: 45419363
1999
1999
Comparison of Risperidone and Mosapramine Addition to Neuroleptic Treatment in Chronic Schizophrenia
Norito Takahashi
,
T. Terao
,
T. Oga
,
M. Okada
Neuropsychobiology
1999
Corpus ID: 6554048
There is little information regarding the effects of risperidone addition to neuroleptic treatment in chronic schizophrenia. As a…
Expand
1997
1997
[Propofol anesthesia for a schizophrenic patient].
H. Sakaguchi
,
H. Taguchi
,
K. Ushijima
Masui. The Japanese journal of anesthesiology
1997
Corpus ID: 26733191
A 41-year-old man weighing 68 kg was scheduled for bilateral tonsillectomy because of palmoplantar pustulosis. The patient had…
Expand
1996
1996
[The affinities of mosapramine for the dopamine receptor subtypes in human cell lines expressing D2, D3 and D4 receptors].
T. Futamura
,
Y. Ohashi
,
K. Yano
,
Y. Takahashi
,
K. Haga
,
T. Fukuda
Nihon yakurigaku zasshi. Folia pharmacologica…
1996
Corpus ID: 8514929
The affinities of mosapramine hydrochloride, an iminodibenzyl antipsychotic drug, for dopamine receptor subtypes were determined…
Expand
1995
1995
[Quantitative autoradiographic analysis of the binding of mosapramine to dopamine D3-receptors].
T. Futamura
,
T. Shimokawa
,
Y. Morio
,
K. Haga
,
T. Fukuda
Nihon yakurigaku zasshi. Folia pharmacologica…
1995
Corpus ID: 26515295
The affinity of mosapramine, an iminodibenzyl antipsychotic, to dopamine D3-receptors in rat brain was investigated by…
Expand
1995
1995
Drug efficacy prediction for schizophrenia.Cases of Haloperidol and Mosapramine.
T. Hayano
1995
Corpus ID: 58053739
1993
1993
Syntheses and biological activities of optical isomers of 3-chloro-5-[3-(2-oxo-1,2,3,5,6,7,8,8a-octahydroimidazo[1,2-a]pyridine- 3-spiro-4'-piperidino)propyl]-10,11-dihydro-5H-dibenz[b,f]azepine…
C. Tashiro
,
S. Setoguchi
,
T. Fukuda
,
N. Marubayashi
Chemical and pharmaceutical bulletin
1993
Corpus ID: 21531933
Mosapramine (1) is a new neuroleptic drug with an asymmetric carbon atom (8a) in its imidazopyridine ring. The enantiomers of…
Expand
1992
1992
[Synthesis of metabolites of mosapramine. I. Synthesis of alcoholic metabolites].
C. Tashiro
,
S. Yuasa
,
K. Demizu
Yakugaku zasshi : Journal of the Pharmaceutical…
1992
Corpus ID: 43021759
Four alcoholic metabolites of (+-)-3-chloro-5-[3-(2-oxo-1,2,3,5,6,7,8,8a-octahydroimidazo[1,2-a] pyridine-3-spiro-4'-peperidino…
Expand
1992
1992
[Synthesis of metabolites of mosapramine. II. Synthesis of phenolic metabolites of mosapramine and their pharmacological activities].
C. Tashiro
,
S. Yuasa
,
T. Fukuda
Yakugaku zasshi : Journal of the Pharmaceutical…
1992
Corpus ID: 9206276
Four phenolic metabolites of (+-)-3-chloro-5-[3-(2-oxo-1,2,3,5,6,7,8,8a-octahydroimidazo[1,2- a]pyridine-3-spiro-4'-piperidino…
Expand
1992
1992
[Effects of mosapramine (Y-516), a new dopamine D2 antagonist, on reverse tolerance after repeated administration of methamphetamine by means of the ambulation-increasing effect in mice].
Y. Uchihashi
,
T. Morimoto
,
S. Tadokoro
Nihon yakurigaku zasshi. Folia pharmacologica…
1992
Corpus ID: 21558453
Effects of mosapramine (Y-516), a new dopamine D2 antagonist, on reverse tolerance (sensitization) after repeated administration…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE